Say No to Immunotherapy (Update 2017)

Say No to Immunotherapy (Update 2017)

Say No to Immunotherapy (Update 2017)

Abstract: Immunotherapy does not cure cancer, and it barely induces remission. It is the most toxic treatment on the market. It is no better than traditional chemotherapy. I discuss a study on immunotherapy of melanoma. It is based on a surrogate endpoint which paves the way for a misleading interpretation of data
.
A new study published recently has exposed major flaws in the fast tracking of some drugs available to the American public without any stringent clinical evidence of their benefits. Many US patients with serious illnesses are being treated by drugs which have questionable data. [ ]drugs given “accelerated approval” by the Food and Drug Administration (FDA) without any strong clinical evaluation.

I discussed these flaws in several presentations:
1. Data manipulation with surrogate Endpoints
2. FDA approves flawed cancer drugs
3. Manipulation of Clinical Trial Results
4. Most new Oncology Drugs do not cure Cancer
5. Surrogate Endpoint Fallacy

I discuss a study on immunotherapy of melanoma. It is based on a surrogate endpoint which paves the way for a misleading interpretation of data. Tumor size is a surrogate endpoint.

Chemotherapy reduces tumor cell birth rate. Immunotherapy raises tumor cell death rate.
Immunotherapy does not cure. It barely induces remission. Yet it is far more toxic than chemotherapy. Treatment with immunotherapies results in a unique and distinct spectrum of adverse events”
These “adverse events” are grave diseases.
Stay away from immunotherapy!